Leading law firm Glancy Prongay & Murray LLP (“GPM”) has launched an investigation into Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN) concerning potential violations of federal securities laws. Investors who have incurred losses or are considering pursuing claims under the relevant laws can submit their contact information at www.glancylaw.com. The investigation focuses on accounting errors related to collaboration agreements, and as a result, the Company’s previously-issued financial statements for fiscal years dating back to January 2020 will be restated.
Following the announcement of the accounting errors, Ocugen’s stock price fell by 10.4%, causing harm to investors. This prompted the need for a thorough investigation to determine the full extent of any potential wrongdoing. If you have non-public information about Ocugen, GPM recommends considering your options to contribute to the investigation or utilizing the SEC Whistleblower Program, which may provide rewards of up to 30% of any successful recovery made by the SEC.
GPM is a highly respected law firm with a sterling reputation in representing investors and consumers in complex class action litigation, including securities litigation. With a team of almost 40 attorneys across four offices nationwide, GPM has achieved significant victories and recovered billions of dollars for its clients in a variety of cases related to corporate misconduct. The firm’s successes have been widely recognized by leading news and industry publications.
Please note that this press release may be considered Attorney Advertising in some jurisdictions in accordance with applicable laws and ethical rules.
For more information about Glancy Prongay & Murray LLP and their ongoing investigations, please visit www.glancylaw.com or contact:
Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, Esq.
Phone: 310-201-9150 or 888-773-9224
Address: 1925 Century Park East, Suite 2100, Los Angeles, CA 90067
Email: [email protected]
Website: www.glancylaw.com
Source: Business Wire
The article discusses how leading law firm Glancy Prongay & Murray LLP (GPM) has launched an investigation into Ocugen, Inc. (NASDAQ: OCGN) for potential violations of federal securities laws. The investigation specifically focuses on accounting errors related to collaboration agreements, which will result in Ocugen restating its financial statements for fiscal years dating back to January 2020. Following the announcement of the accounting errors, Ocugen’s stock price fell by 10.4%, causing harm to investors.
One of the most pressing questions relevant to this topic is the potential impact of the investigation on Ocugen’s future financial performance and investor confidence. If the investigation reveals serious violations of securities laws, it could lead to legal consequences and further decline in the company’s stock price. On the other hand, if the investigation clears Ocugen of any wrongdoing, it may restore investor confidence and potentially boost the stock price.
Another important aspect to consider is the potential regulatory actions that may result from this investigation. Depending on the severity of the violations, the Securities and Exchange Commission (SEC) may take action against Ocugen, which could range from fines to more stringent regulatory oversight. This can have long-term implications for the company and its operations.
It is worth noting that the SEC Whistleblower Program is highlighted as an option for individuals who have non-public information about Ocugen. This program allows whistleblowers to report potential securities violations anonymously and may provide rewards of up to 30% of any successful recovery made by the SEC. This could incentivize individuals to come forward with information that could aid the investigation.
In terms of market trends, the pharmaceutical industry, in general, is experiencing significant growth due to the ongoing COVID-19 pandemic and increased focus on healthcare. However, the specific challenges and controversies associated with Ocugen’s potential securities law violations may limit its ability to fully capitalize on these trends. Investor sentiment towards the company can be negatively impacted, which can hinder its growth prospects and access to capital.
Advantages of a thorough investigation into potential securities law violations include holding the company accountable for any wrongdoing and providing clarity and transparency to investors. If any violations are found, it can help prevent similar incidents in the future and maintain the integrity of the financial markets.
On the other hand, a prolonged investigation can create uncertainties for the company and its stakeholders, causing a loss of confidence and potential damage to its reputation. The reputational damage can have long-term consequences beyond the immediate financial impact.
For more information about Glancy Prongay & Murray LLP and their ongoing investigations, you can visit their website at www.glancylaw.com.
Overall, the investigation into Ocugen’s potential securities law violations has raised concerns about the company’s financial statements and investor confidence. The outcomes of the investigation and any subsequent regulatory actions will play a crucial role in determining the company’s future prospects and market reputation.